Literature DB >> 8543750

Development of immune response to cow's milk proteins in infants receiving cow's milk or hydrolyzed formula.

O Vaarala1, T Saukkonen, E Savilahti, T Klemola, H K Akerblom.   

Abstract

BACKGROUND: Development of humoral and cellular immune responses to orally administered antigens in human beings is poorly understood, although antigen administration has been suggested as a treatment for hypersensitivity disorders and autoimmune diseases.
OBJECTIVE: The purpose of the study was to investigate the development of systemic immune response in infants fed with formula containing whole cow's milk proteins or hydrolyzed formula containing casein peptides.
METHODS: In a double-blind trial, 10 infants received cow's milk-based formula, and 10 infants received a casein hydrolysate formula until the age of 9 months. Blood samples were taken at the ages of 6, 9, and 12 months. Cellular responses were assessed by proliferation assay of peripheral blood mononuclear cells to cow's milk proteins (beta-lactoglobulin, bovine serum albumin, and alpha-casein). Humoral responses to the same proteins were measured by ELISA for IgG antibodies.
RESULTS: Feeding infants with cow's milk-based formula induced systemic humoral and cellular responses to cow's milk proteins. T-cell response later declined, supporting the concept of oral tolerization. Exposure to cow's milk proteins after the age of 9 months resulted in depressed cellular and humoral responsiveness to these proteins.
CONCLUSION: Our results support the view that induction of oral tolerance in human beings is an age-dependent phenomenon.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543750     DOI: 10.1016/s0091-6749(95)70229-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

Review 1.  Environmental triggers and determinants of beta-cell autoimmunity and type 1 diabetes.

Authors:  Mikael Knip
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study.

Authors:  H K Akerblom; S M Virtanen; J Ilonen; E Savilahti; O Vaarala; A Reunanen; K Teramo; A-M Hämäläinen; J Paronen; M-A Riikjärv; A Ormisson; J Ludvigsson; H-M Dosch; T Hakulinen; M Knip
Journal:  Diabetologia       Date:  2005-04-19       Impact factor: 10.122

Review 3.  Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR).

Authors:  Mikael Knip; Suvi M Virtanen; Dorothy Becker; John Dupré; Jeffrey P Krischer; Hans K Åkerblom
Journal:  Am J Clin Nutr       Date:  2011-06-08       Impact factor: 7.045

4.  Differential binding of IgG and IgA antibodies to antigenic determinants of bovine serum albumin.

Authors:  C Hilger; F Grigioni; C De Beaufort; G Michel; J Freilinger; F Hentges
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

5.  Insulin autoantibodies with high affinity to the bovine milk protein alpha casein.

Authors:  K Adler; D B Mueller; P Achenbach; S Krause; A-K Heninger; A G Ziegler; E Bonifacio
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

Review 6.  Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.

Authors:  David A Osborn; John Kh Sinn; Lisa J Jones
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

7.  Feasibility and compliance in a nutritional primary prevention trial in infants at increased risk for type 1 diabetes.

Authors:  S M Virtanen; S Bärlund; M Salonen; E Savilahti; A Reunanen; J Paronen; A-M Hämäläinen; J Ilonen; K Teramo; M Erkkola; A Ormisson; Ü Einberg; M-A Riikjärv; J G Ludvigsson; M Knip; H K Åkerblom
Journal:  Acta Paediatr       Date:  2011-01-10       Impact factor: 2.299

8.  Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood.

Authors:  Kristiina Luopajärvi; Erkki Savilahti; Suvi M Virtanen; Jorma Ilonen; Mikael Knip; Hans K Akerblom; Outi Vaarala
Journal:  Pediatr Diabetes       Date:  2008-05-21       Impact factor: 4.866

9.  The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up.

Authors:  H K Akerblom; J Krischer; S M Virtanen; C Berseth; D Becker; J Dupré; J Ilonen; M Trucco; E Savilahti; K Koski; E Pajakkala; M Fransiscus; G Lough; B Bradley; M Koski; M Knip
Journal:  Diabetologia       Date:  2010-12-12       Impact factor: 10.122

10.  Infant formulas containing hydrolysed protein for prevention of allergic disease.

Authors:  David A Osborn; John Kh Sinn; Lisa J Jones
Journal:  Cochrane Database Syst Rev       Date:  2018-10-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.